5 Ovarian Cancer Clinical Trials in Mobile, AL (2026)

Q: How do I join a clinical trial in Mobile?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you.

Recruiting Ovarian Cancer Studies in Mobile

NCT05128825Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Canc...

Mobile, ALPHASE2310 participantsK-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

View Study Details

NCT05281471Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active...

Mobile, ALPHASE3186 participantsGenelux Corporation

View Study Details

NCT05554328Recruiting

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back ...

Mobile, ALPHASE2165 participantsNational Cancer Institute (NCI)

View Study Details

NCT07023627Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With Cyclin E1 Overexpression....

Mobile, ALPHASE2160 participantsIncyte Corporation

View Study Details

NCT06890338Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy of neoadjuvant carboplatin and mirvetuxim...

Mobile, ALPHASE2140 participantsAbbVie

View Study Details

About Ovarian Cancer Clinical Trials in Mobile

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 5 ovarian cancer clinical trials recruiting participants in Mobile, AL. These studies are seeking a combined 961 participants. Research is being sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc, Genelux Corporation, National Cancer Institute (NCI) and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Mobile — FAQ

Are there ovarian cancer clinical trials in Mobile?

Yes, there are 5 ovarian cancer clinical trials currently recruiting in Mobile, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mobile?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.

Are clinical trials in Mobile free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 5 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated July 20, 2026 from ClinicalTrials.gov